Next 10 |
Source: Shutterstock The stock market has continued to edge higher and the two major indexes, the Nasdaq ( QQQ ) and S&P 500 ( SPY ), touched the all-time high milestone last week. The steady gain reflects a diminishing concern relating to the pace of a global economic slowdown, as m...
Quick Take Hookipa Pharma ( HOOK ) has filed proposed terms to raise $100 million in a U.S. IPO, per an amended registration statement . Hookipa is advancing a pipeline of immunotherapeutics for infectious diseases and cancers. HOOK has generated promising trial results for its lead can...
Merger activity decreased last week with one new deal announced and five pending deals closing. Deal Statistics New Deals The acquisition of AmeriGas Partners (APU) by UGI Corporation (UGI) for $6.66 billion in a cash plus stock deal. Under the terms of the agreement, AmeriGas un...
Below is a snapshot of total returns across asset classes using key ETFs traded on US exchanges. For each ETF, we show its total return over the last 12 months, year-to-date through Q1, and in March. In the US, smallcap ETFs like [[IJR]] and [[IWM]] lagged badly in March, and they're only up...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of common stock of Immune Design (NASDAQ: IMDZ) at a purchase price of $5.85 per share. As of the tender...
(Rendition of Brain Neurons, Source: NIH) The biotech sector has continued to participate in the market rally. One of the reasons is the strength in biopharma M&A activity, which provides unique support for valuations and particularly assists the small-and-midcap biotech companies. We ...
This article explains the reasons behind the movement in a selection of the largest U.S. cash merger arbitrage spreads from the past week as calculated by Merger Arbitrage Limited. We analyze the attractiveness and profitability of each spread going forward and indicate the trading position ...
Merger activity increased last week with four new deals announced and four pending deals closing. Deal Statistics: New Deals: The acquisition of Immune Design (IMDZ) by Merck (MRK) for $300 million or $5.85 per share in cash. The acquisition of Citizens First Corporation (C...
On Monday, February 25th, Generex (GNBT) will distribute shares in its subsidiary Antigen Express at a rate of one share for every four shares of Generex to shareholders of record on January 30, 2019. If there are about 60 million Generex shares, that means that there will be 15 million shares...
HENDERSON, NV / ACCESSWIRE / February 22, 2019 / Below are several healthcare companies in the news leading the sector recently. A company in the sector that has not had news recently but according to their website, "has an open IND (Investigational New Drug) and has agreed with the FDA on a...
News, Short Squeeze, Breakout and More Instantly...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of common stock of Immune Design (NASDAQ: IMDZ) at a purchase price of $5.85 per share. As of the tender...
HENDERSON, NV / ACCESSWIRE / February 22, 2019 / Below are several healthcare companies in the news leading the sector recently. A company in the sector that has not had news recently but according to their website, "has an open IND (Investigational New Drug) and has agreed with the FDA on a...
CORAL GABLES, FL / ACCESSWIRE / February 21, 2019 / The recent success of the healthcare stock market can be attributed to the fact that companies in the healthcare industry are looking into new innovative approaches and technologies to better improve their offerings for consumers. Whereas...